Observed signal
High screening-priority population
0
Evidence basis: Current priority universe; screening score threshold >=70
Review use: Persistent or rising high-priority counts warrant deeper evidence review.
Flags, not forecasts
These indicators are triage signals for further review. They do not predict insolvency, wrongdoing, credit default or investment performance. A flag should only become a conclusion after source verification and appropriate professional review.
Observed signal
Accounts stress flags
6
Evidence basis: Accounts evidence review score threshold >=60
Review use: Look for persistence, deteriorating balance-sheet indicators and filing delays.
Observed signal
Potential overdue accounts
0
Evidence basis: Companies House accounts status/due-date enrichment where available
Review use: Verify against the latest Companies House filing record before drawing conclusions.
Observed signal
Outstanding security/charge signals
245
Evidence basis: Targeted Companies House charge records not marked satisfied
Review use: Changes in secured-lender exposure can justify follow-up, but are not adverse findings by themselves.
Observed signal
Officer-change signals
193
Evidence basis: Targeted officer appointment records containing resignation dates
Review use: Clusters of changes can be a review trigger when combined with other evidence.
Observed signal
Dense address clusters
32,148
Evidence basis: Current address concentration output with 10+ linked companies where available
Review use: Growth or concentration at shared addresses may merit network and provenance checks.
Live weekly freshness
Checking the current weekly evidence pack…
Escalation rule
Prioritise combinations: accounts stress plus officer churn, new secured lending plus filing deterioration, or persistent high screening priority across several periods.
Historical rule
Prefer acceleration and persistence over one-off values. The Historical page remains the evidence layer for month-to-month movement.
Evidence rule
Every review should retain the source period, observation date and underlying Companies House evidence before any external use.